Registry Study of Proton Radiotherapy in Lymphoma
ConditionMediastinal Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Heidelberg
About this trial
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Eligibility criteria
Qualifiers
Patient consent
Patient age ≥18 years.
Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
Ability of the patient to give consent
Disqualifiers
Non-consent of the patient to the disclosure of his data
Cancellation of the patient's participation in the study
Trial design
Treatments tested in this trial
- Assesment of Effectiveness and side effects
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov